As of 2024-12-15, the Relative Valuation of Alpine Immune Sciences Inc (ALPN) is (21.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 64.97 USD, the upside of Alpine Immune Sciences Inc based on Relative Valuation is -133.2%.
The range of the Relative Valuation is (18.47) - (25.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.4x - 59.8x | 47.1x |
| Forward P/E multiples | 19.4x - 47.1x | 33.2x |
| Fair Price | (18.47) - (25.29) | (21.57) |
| Upside | -128.4% - -138.9% | -133.2% |
| Date | P/E |